C5AR1 and neoplasm: Although the growth of squamous cell carcinoma in mice was not significantly affected by either paclitaxel or C5aR1 antagonist PMX-53 monotherapy, the combination of both treatments was synergistically effective in reducing tumour growth rate [17].